Canada markets close in 3 hours 59 minutes

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.2820+0.0020 (+0.71%)
As of 12:00PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,680
1,558
1,363
285
0
Operating Expenses
Research Development
53,671
48,029
38,797
29,694
12,522
Selling General and Administrative
19,748
19,057
17,556
14,206
9,687
Total Operating Expenses
73,419
67,086
56,353
43,900
22,209
Operating Income or Loss
-71,739
-65,528
-54,990
-43,615
-22,209
Total Other Income/Expenses Net
-
-1,592
-1,316
-
-
Income Before Tax
-68,818
-62,621
-55,265
-43,513
-22,127
Income Tax Expense
59
59
13
0
-
Income from Continuing Operations
-68,877
-62,680
-55,278
-43,513
-22,127
Net Income
-68,877
-62,680
-55,278
-43,513
-22,127
Net Income available to common shareholders
-68,877
-62,680
-55,278
-43,513
-22,242
Basic EPS
-1.40
-1.26
-1.83
-3.35
-2.59
Diluted EPS
-1.40
-1.26
-1.83
-3.35
-2.59
Basic Average Shares
43,646
49,804
30,236
12,986
8,590
Diluted Average Shares
43,646
49,804
30,236
12,986
8,590